Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2026-10-14
• Last 15 days FTD volume: HK$2.69 M
• Last 3 months FTD volume: HK$4.15 M
• Last 12 months FTD volume: HK$0.10 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	HK$38.26 M	HK$0.34 B	🇺🇸 USA
AbbVie ABBV	HK$56.92 M	HK$0.32 B	🇺🇸 USA
Eli Lilly LLY	HK$40.93 M	HK$0.36 B	🇺🇸 USA
Repligen RGEN	HK$12.82 M	HK$59.36 M	🇺🇸 USA
Athersys ATHX	HK$0.09 M	HK$0.71 M	🇺🇸 USA
ANI Pharmaceuticals ANIP	HK$1.5 M	HK$5.2 M	🇺🇸 USA
Palatin Technologies PTN	HK$2.44 M	HK$3.76 M	🇺🇸 USA
Royalty Pharma RPRX	HK$13.29 M	HK$0.36 B	🇬🇧 UK